Sangamo Therapeutics (SGMOQ) Short-term Investments (2010 - 2025)

Sangamo Therapeutics' Short-term Investments history runs 15 years deep, the most recent figure standing at $912000.0 for Q3 2025.

• On a quarterly basis, Short-term Investments changed N/A year-over-year to $912000.0 in Q3 2025; TTM through Sep 2025 was $912000.0, a N/A change from a year earlier, with the FY2021 full-year figure at $197.7 million, down 61.25% from the prior year.
• Short-term Investments eased to $912000.0 in Q3 2025 per SGMOQ's latest filing, from $75.6 million in the prior quarter.
• Across five years, Short-term Investments topped out at $464.1 million in Q1 2021 and bottomed at $912000.0 in Q3 2025.
• The 4-year median for Short-term Investments is $197.8 million (2021), against an average of $203.5 million.
• Across the five-year window, Short-term Investments soared 82.25% in 2021 and tumbled 65.48% in 2023, its largest moves.
• Year by year, Short-term Investments stood at $197.7 million in 2021, then increased by 10.79% to $219.0 million in 2022, then tumbled by 65.48% to $75.6 million in 2023, then slumped by 98.79% to $912000.0 in 2025.
• Per Business Quant, the three latest SGMOQ Short-term Investments figures stand at $912000.0 (Q3 2025), $75.6 million (Q3 2023), and $76.3 million (Q2 2023).